Okta Cl A saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 85 to 97.
The revised score means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength.
Okta Cl A is currently forming a cup without handle, with a 114.50 buy point. See if the stock can break out in heavy trade at least 40% above average.
Lean How — And When — To Sell Stocks
One weak spot is the company's 72 EPS Rating, which tracks quarterly and annual earnings growth. Look for that to improve to 80 or better to show it's in the top 20% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q4, the company posted 24% earnings-per-share growth. Revenue growth fell to 13%, down from 14% in the prior quarter.
Okta Cl A holds the No. 4 rank among its peers in the Computer Software-Security industry group. CrowdStrike Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
